1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Why the Deal for AveXis Is a Powerful Vote for Replacement Gene … – Barron’s

Continue reading

2018-04-09 NEWS

Barron’s

Why the Deal for AveXis Is a Powerful Vote for Replacement Gene …
Barron’s
Novartis’s $8.7 billion deal to buy AveXis, one of the leaders in replacement gene therapy, amounts to a strong endorsement of the developing biotechnology. It also looks bullish for Regenxbio, which makes the viral delivery mechanism for AveXis’s …
How a Rockville company benefits from Novartis’ $8.7B purchase of a Chicago biotechWashington Business Journal
Analyst: AveXis M&A Could Support Interest In RegenxbioBenzinga
Zacks Premium Investment Service – Zacks.comZacks
SEC.gov
all 47 news articles »
Continue reading

2018-04-09 NEWS

Barron’s

Why the Deal for AveXis Is a Powerful Vote for Replacement Gene …
Barron’s
Novartis’s $8.7 billion deal to buy AveXis, one of the leaders in replacement gene therapy, amounts to a strong endorsement of the developing biotechnology. It also looks bullish for Regenxbio, which makes the viral delivery mechanism for AveXis’s …
How a Rockville company benefits from Novartis’ $8.7B purchase of a Chicago biotechWashington Business Journal
Zacks Premium Investment Service – Zacks.comZacks
X0306 4 2018-03-13 false 0001590877 REGENXBIO Inc. RGNX 0001346164 Simpson Curran C/O REGENXBIO INC …SEC.gov

all 47 news articles »
Continue reading

2018-04-09 NEWS

Atlanta Journal Constitution

Even after FDA warnings, stem cell clinics still turning hope into hype
Atlanta Journal Constitution
Dr. Mark Berman, of the California-based Cell Surgical Network, collects fat from a patient’s back as part of an experimental stem cell procedure. Berman’s company is one of many for-profit clinics that market stem cells to patients to treat dozens of …
It’s all about the (stem cell) neighborhood — ScienceDailyScience Daily
The structure and function of a controller of stem cell divisionPhys.Org
Are we on the brink of a stem cell revolution? – The TelegraphTelegraph.co.uk
The Times –Medical Dialogues
all 29 news articles »
Continue reading

2018-04-09 NEWS

Forbes

Why Did Novartis Spend $9 Billion On Gene Therapy? CEO Says: ‘A Journey To Focus On Data And Digital’
Forbes
This morning, Novartis announced it would buy gene therapy pioneer AveXis for $8.7 billion, giving the Swiss drug giant several treatments for rare diseases that work by inserting new DNA into patients’ cells. AveXis shares rose 78% to nearly match the …
Why the Deal for AveXis Is a Powerful Vote for Replacement Gene TherapyBarron’s
Why Novartis Is Paying $8.7 Billion for a Gene Therapy Developer You’ve Never Heard OfFortune
Novartis enters deal to acquire gene therapy company AveXis for $8.7 billionCNBC
Wall Street Journal –USA TODAY –STAT –Zacks
all 131 news articles »
Continue reading

2018-04-09 NEWS

Foreign Affairs

Media alert: New articles in The CRISPR Journal | EurekAlert …
EurekAlert (press release)
This press release is issued on behalf of The CRISPR Journal, a peer-reviewed journal from Mary Ann Liebert Inc. dedicated to publishing outstanding research and commentary in all aspects of CRISPR and gene editing research.
Bill Gates on What Gene Editing and CRISPR Means for Public …Foreign Affairs
CRISPR might one day reverse devastating brain diseasesSTAT
Researcher speeds up CRISPR’s gene editing ability – UPI.comUPI.com
Phys.Org –News-Medical.net –Massive
all 15 news articles »
Continue reading

2018-04-09 NEWS
Recent Posts
Blog Categories
Blog Categories
Blog Categories
Blog Categories
Blog Categories

What We’re Reading: VA Nominee and Retirement Choice; Mega Deals and PCPs; Novartis Buys Gene Therapy Firm
AJMC.com Managed Markets Network
Ronny L. Jackson, MD, would give up $1 million in retirement income to head the Department of Veterans Affairs and work in the Trump administration; mega healthcare deals endanger independent practices of primary care providers; Novartis is buying a …

and more »